ReCode in the News
Press Releases
ReCode, Cystic Fibrosis Foundation Advance CF Gene Therapies
ReCode Announces Two Key Additions to Scientific Advisory Board
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today presented preclinical
ReCode Therapeutics Presents Preclinical Data from its Cystic Fibrosis Program at the 2024 North American Cystic Fibrosis Conference (NACFC) in Boston
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today presented preclinical
Presentations
Aerosolized lipid nanoparticle/mRNA therapy to treat patients with Cystic Fibrosis
2023 Cilia, Mucus and Mucociliary Interactions GRC
Publications & Abstracts
Featured News
Unshackling genetic medicines by enabling delivery beyond the liver
Nature Biopharma Dealmakers
Media Contacts
ReCode Therapeutics
Erica Jefferson
[email protected]
The Grace Group
Tara Cooper
[email protected]
[email protected]
Investor Contact
Stern IR
AnneMarie Fields
[email protected]
[email protected]
Media Library
Download assets including ReCode’s logo, high-resolution headshots, and fact sheets.